2007 BIO International Convention Exhibitor Profiles Continued, M Through Z
Posted on: Thursday, 3 May 2007, 12:00 CDT
2007 BIO International Convention, the Global Event for Biotechnology, takes place May 06 - 09, 2007 at the Boston Convention & Exhibition Center. For in-depth information about the event, visit http://www.bio2007.org/Media/releases.html.
Below are profiles from BIO exhibitors, listed M through Z.
Business Wire is the official news wire for 2007 BIO International Convention. Breaking news releases and photos are available at Tradeshownews.com, Business Wire's trade show, conference, and event news resource as well as the official show site.
Company:
Maxiom Group
Booth:
Booth 533/Pod D12
Media Contact:
Jennifer Fiorentino
Phone:
781-239-1030
E-mail:
jfiorentino@parnold.com
Web:
www.maxiomgroup.com
Maxiom Group is a leading strategic business and IT consulting firm exclusively serving the life sciences industry. Located in Waltham, Massachusetts, Maxiom Group specializes in transforming emerging, established, and mature biotechnology, pharmaceutical, and medical device companies at each stage of their life cycle by solving mission critical business issues. From drug discovery and development, to clinical trials, to commercial launch and sustained market leadership, Maxiom Group clients rely on our unique focus, insight and approach. For more information please visit www.maxiomgroup.com.
Company:
MEDICEN PARIS REGION
Booth:
1307
Media Contact:
Isabelle Boyer de la Giroday
Phone:
33 1 44 49 30 00
E-mail:
igiroday@medicen.org
Web:
www.medicen.org
Medicen Paris Region unites all the key life science and healthcare players in the Paris metropolitan area. Located at the heart of Europe's leading regional economy, the cluster brings together the highest concentration of healthcare expertise and resources in Europe.
This ambition is shared by major pharmaceutical and healthcare companies, biotech & medtech entrepreneurs, public and private research organizations, Europe's leading hospital network and the region's universities and Grandes Écoles.
These stakeholders are developing close partnerships and active collaborations around innovative projects, company start-ups and business creation. For additional information email contact@medicen.org.
Company:
MedMira Laboratories Inc.
Booth:
807 -- Atlantic Canada Pavilion
Ticker Symbol & Exchange:
MIR TSX Venture exchange
Media Contact:
Dr. James Smith -- VP -- Corporate Affairs and Human Resources
Phone:
902 450 1588
E-mail:
ir@medmira.com
Web:
www.medmira.com
MedMira's focus is helping people know...®. We do this by bringing quality diagnostic solutions closer to end-users -- laboratory professionals, healthcare providers and individuals.
In a world continually faced with overwhelming healthcare epidemics and challenges, healthcare providers, researchers, governments and businesses are not standing still and neither is MedMira. We have a robust line of rapid diagnostics for today's healthcare challenges. The tools we provide can help control and prevent the HIV and Hepatitis C epidemics from reaching future generations. Today, HIV and Hepatitis C are two of the top 10 causes of infectious disease deaths worldwide.
MedMira is developing revolutionary solutions to prevent tomorrow's epidemics. As we continue to build on our line of rapid diagnostics, we are expanding our focus to confirmatory testing, offering customers an end-to-end diagnostic solution. Through our Maple Biosciences division, we are en route to changing the face of laboratory diagnostics with biosensor technologies, which will make the routine laboratory tests of today obsolete, improving both the delivery of healthcare and the patient experience.
Company:
Meissner Filtration Products, Inc.
Booth:
2469
Media Contact:
Karisa Koenig
Phone:
805-388-9911
E-mail:
karisak@meissner.com
Web:
www.meissner.com
From clinical trials through full-scale production, Meissner offers leading filtration solutions for your process. Meissner Technical Services (MTS) provides complete validation services, documentation & customer support to select/size/install/maximize filtration systems. Membrane filters (0.04-1.0 µm absolute) include SteriLUX® PVDF, STyLUX® and EverLUX™ PES, Chemdyne® Polypropylene (PP) and Ultradyne® PTFE. Microfiber prefilters in ALpHA® PP, Protec™ RF borosilicate glass and Protec™ RM dual-layer glass/PVDF membrane & DeltaMax&8482; PP depth filters are offered. Configurations include syringe filters, discs, capsules, high-capacity UltraCap®/UltraCap® H.D. (Heavy Duty) capsules, cartridges & DPS™ (Disposable Processing System) filter/bio-container assemblies.
Company:
MetaMorphix, Inc.
Booth:
#490 -- Maryland Pavilion
Media Contact:
Theresa Brady
Phone:
301.575.2505 C: 410.533.6328
E-mail:
tbrady@metamorphixinc.com
Web:
www.metamorphixinc.com
MetaMorphix is a leader in providing DNA analytical services to canine registry organizations. These services include parentage testing and pedigree certification. MMI Genomics, a wholly-owned subsidiary of MetaMorphix, Inc., is the principal DNA analytical service provider for the AKC and the UKC, the two largest breed registrations in the United States.
The Canine Heritage ™ Breed Test is the most recent product to come from MMI's exclusive, state-of-the-art, SNP-based DNA technology. The test genetically identifies the composition of mixed breed dogs. Currently the test can identify 38 major breeds which make up approximately 75% of the domestic canine purebred population.
Company:
Missouri Biotechnology Association (MOBIO) and Missouri Department of Economic Development
Booth:
2145
Media Contact:
Cheri Winchester
Phone:
636-262-8313
E-mail:
cwinchester@commongroundpr.com
Web:
www.mobio.org
From earning constitutional protection for stem cell research to converting tobacco plants into cancer-fighting drugs, Missouri has proven to be more than a fly-over state for biotechnology research.
For reporters interested in covering the latest agriculture and human health advances courtesy of biotechnology research, we can connect them with the people and organizations behind the breakthrough science, addressing timely issues from biodiesel to the latest plant biotech traits and stem cell research. Also learn why global biotech institutions are investing several hundred million dollars in current construction of new bioscience capital investments in Missouri.
Company:
MMG
Booth:
600
Media Contact:
Whitney Brimfield
Phone:
301-984-7191
E-mail:
mmg@mmgct.com
Web:
www.wegetpatients.com
At MMG, we focus on the best ways to identify sites and reach patients for your clinical trials. During our 20-year history we've brought together some of the nation's leading experts in clinical trial recruitment and retention. Nobody understands patients, their healthcare providers, and how to reach them like MMG.
Company:
MPI Research
Booth:
2273
Media Contact:
Peggy Foster
Phone:
269-668-3336 ext. 1817
E-mail:
Peggy.foster@mpiresearch.com
Web:
www.mpiresearch.com
MPI Research is a full service Contract Research Organization that serves the biotech and the pharmaceutical industries in meeting their nonclinical and early clinical drug development research needs, from discovery to regulatory submission. Known for our state-of-the-art facilities, excellent study quality, regulatory experience, AAALAC accreditation, and GLP compliance, we partner with our Sponsors in delivering on time, high quality, innovative and cost-effective solutions. From single study protocols to multiple projects across our broad scope of services, we have the capacity and resources to start your studies promptly so that you can achieve your project milestones. For complete information, visit our website at www.mpiresearch.com.
Company:
MSOURCE
Booth:
Belgian Pavilion/Flanders BIO
Media Contact:
Adriaan Hart de Ruyter
Phone:
32 2 768 01 66
E-mail:
info@msource-cro.com
Web:
www.msource-cro.com
MSOURCE offers Clinical Insourcing & Outsourcing services across Europe:
•Clinical Contract Hire
--Temporary staffing of qualified clinical research employees working under MSOURCE contract
•Clinical Trial Management
--Phase I to IV clinical trials
--From Study design till Final Study report
•Clinical Data Management and Biostatistical Services
--Clinical Data Management for development and late phase trials
--Biostatistics and SAS programming
--Medical Writing
•Quality Assurance & Regulatory Consulting
--Consultants, trainers and auditors with strong clinical background.
•Pharmacovigilance and Medical Affairs
--EU CTD Compliant handling/reporting of SAE's
--Medical/Scientific consulting
Company:
Multiple Myeloma Research Foundation
Booth:
3221
Media Contact:
Anne Quinn Young
Phone:
203-652-0212
E-mail:
Quinnyounga@themmrf.org
Web:
www.multiplemyeloma.org
The mission of the MMRF is to invest urgently and aggressively in research that will get treatments to patients as fast as possible and ultimately find a cure for myeloma.
The MMRF supports one of the scientific community's most innovative and responsive research grant programs. They are the #1 private funder of myeloma-specific research worldwide, and will disseminate $11 million in funding in 2007. Visit www.multiplemyeloma.org to learn more.
Company:
Murphy & McManus, LLC
Booth:
533
Media Contact:
Robert Murphy
Phone:
781-444-3510
E-mail:
rmurphy@murphymcmanus.com
Web:
www.murphymcmanus.com
For more than 17 years, Murphy & McManus has assisted clients in managing major capital projects to ensure budget, schedule, and performance objectives are achieved and exceeded. Murphy & McManus is a qualified Project Management firm with a staff of expert financial, architectural, engineering, and construction professionals that provide a multi-disciplined approach to executing a project. We have developed a set of systems and controls to provide accurate and effective planning, estimating, forecasting, and scheduling. Our systems and expert advice enable our clients to make timely and informed project decisions that are critical in the ultimate success on a project.
Company:
National Jewish Medical and Research Center
Booth:
Colorado Pavilion #1483
Media Contact:
William Allstetter
Phone:
(303)398-1002
E-mail:
allstetterw@njc.org
Web:
http://www.nationaljewish.org
National Jewish, a private, nonprofit institution, and the #1 respiratory hospital in the US, conducts groundbreaking clinical and scientific research in the fields of respiratory and allergic diseases, inflammation, and immunology. National Jewish has close to 150 technologies in its active portfolio and owns 55 active issued U.S. patents plus additional corresponding foreign patents. National Jewish ranks in the top 5% of NIH funded institutions in terms of dollars received every year and two HHMI-funded investigators are part of our faculty. We actively seek commercial partners to complement our clinical trial, research, & technology transfer programs.
Company:
NeuroHealing Pharmaceuticals, Inc.
Media Contact:
Daniel Katzman
Phone:
617 331-4111
E-mail:
Daniel@neurohealing.com
Web:
www.neurohealing.com
NeuroHealing is developing therapies to improve the neuro-rehabilitation process and functional outcome for patients who have suffered debilitating injuries to the central nervous system. Clinical stage programs include: NH001 (phase II), a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative or minimally consciousness state; NH004 (phase II), an anticholinergic agent in a convenient intra-orally muco-adhesive dissolving film to help treat Parkinson's and other motor neuron disease patients who suffer from sialorrhea (drooling); and NH02D, a novel mechanism compound to accelerate the rehabilitation outcomes of stroke patients who remain with chronic motor and cognitive disabilities.
Company:
Nevada Development Authority
Booth:
1807
Media Contact:
Riley Meredith, riley@preferredpublicrelations.com, (702) 254-5704
Phone:
888-4-NO-TAXES
E-mail:
info@nevadadevelopment.org
Web:
www.nevadadevelopment.org
The mission of Nevada Development Authority (NDA) is to attract, retain and expand the business base and enhance the overall socioeconomic environment of Southern Nevada. Established in Las Vegas in 1956, NDA is Southern Nevada's largest economic development agency and contributes to the area's prosperity by attracting new companies and assisting local companies in expansion projects.
The Nevada Development Authority has successfully recruited more than 60 businesses to Las Vegas this past fiscal year, including high tech, communications and life science companies. Currently, NDA is implementing a campaign to recruit bio tech and life science businesses on the east coast.
Company:
New Jersey Research Universities
Booth:
1122
Media Contact:
Judith Sheft
Phone:
973-596-5825
E-mail:
sheft@njit.edu
Web:
www.njit.edu / www.rutgers.edu / www.princeton.edu / www.umdnj.edu
New Jersey offers a rich academic environment, housing prestigious colleges and universities and advanced technology development centers. New Jersey Institute of Technology, Princeton University, Rutgers University, the state university of New Jersey and University of Medicine and Dentistry of New Jersey comprise core components of the state's academic research and technology development infrastructure. These universities deliver advances in complementary areas of scientific discovery in the public interest. Successful public/private/academic collaborations have helped support the growth of the state's position as a leader in health care. Areas of key expertise include work in biomedical engineering, neuroscience, nanotechnology, stem cell research, and pharmaceutical engineering.
Company:
Next Generation Clinical Research
Booth:
1145 -- Wisconsin Pavilion
Media Contact:
Matthew Hanson
Phone:
608-835-5811
E-mail:
mhanson@nextgenclinical.com
Web:
www.nextgenclinical.com
Next Generation is a Contract Research Organization (CRO) that provides clinical trial management, monitoring, data management, regulatory affairs and management services to small and mid-sized pharmaceutical and biotechnology organizations. Our specialties include complex projects and trial designs or unique delivery methods in multiple therapeutic areas. We command particular expertise in Nephrology, Bone Disease, Dermatology and Central Nervous System disorders.
Company:
NH, State of & Public Service of NH
Booth:
2133.
Media Contact:
John R. DiNapoli, Business Development Manager
Phone:
603-271-2591 X 114
E-mail:
jrdinapoli@dred.state.nh.us
Web:
www.nheconomy.com
NH, State of and Public Service of NH work together in attracting businesses to NH. Our organizations, along with others (business, government and education) assist companies in creating jobs. Contact our offices for additional details on how your company can benefit by locating/expanding to NH today at (603) 271-1591 or 634-2386 www.nheconomy.com or www.psnh.com
Company:
NHS Innovations London
Booth:
1864
Media Contact:
Laura James
Phone:
44 (0)207 380 1711
E-mail:
laura.james@nhsinnovationslondon.com
Web:
www.nhsinnovationslondon.com
The NHS is the UK's main healthcare provider and its biggest employer of science graduates. It is the 3rd largest organisation in the world and is the biggest recruiter in Europe. As a service with technology at its forefront the NHS is a significant source of healthcare innovations. These innovations fulfill real needs, originating from the day-to-day provision of healthcare.
NHS Innovations London identifies, protects and commercialises the ideas and research of over 65 NHS Hospital Trusts in London including hospitals specialising in cancer, cardiology, heart & lung disease, pediatrics, psychiatric medicine, acute & trauma services and neurosciences with many having world class research facilities and laboratories. NHSIL manages innovations competitions and undertakes IP audits to identify potential inventions. The assessment and development of these technologies is crucial to their success and our best practice evaluation, protection, development and commercialisation process results in a pipeline of technologies with decreased risk and increased value.
Innovations from the NHS span the healthcare industry and include Therapeutics, Diagnostics, Informatics, Medical Devices, Assistive Technologies, Equipment and Surgery
Company:
NicOx
Ticker Symbol & Exchange:
Bloomberg ticker: COX:FP / Reuters ticker: NCOX.PA (EuroNext)
Media Contact:
Irène Lalande
Phone:
33 (0)4 97 24 53 11
E-mail:
lalande@nicox.com
Web:
http://www.nicox.com
NicOx is a product-driven biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs. NicOx is targeting the therapeutic areas of inflammatory and cardio-metabolic diseases. Resources are focused on two lead compounds, naproxcinod, in phase 3 development for the treatment of osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has strategic partnerships with some of the world's leading pharmaceutical companies, including Pfizer Inc. and Merck and Co., Inc.
NicOx S.A. is headquartered in Sophia-Antipolis, France, and is a public company listed on the Eurolist of Euronext Paris (segment: Next Economy).
Company:
NPIL Pharma Torcan
Booth:
507
Media Contact:
Nicole Tingley
Phone:
416.904.4735
E-mail:
Nicole.tingley@torcan.com
Web:
www.npilpharma.com or www.torcan.com
NPIL Pharma is the new global brand in custom manufacturing of RSM, key intermediates, active pharmaceutical ingredients and finished products with operations in India, the UK and Canada.
NPIL creates value across the entire drug development lifecycle by offering integrated services to support preclinical development through to commercialization.
NPIL offers a comprehensive range of chemistry and formulation development services to support preclinical and clinical development. With extensive large-scale assets, including high potency manufacturing, NPIL also offers a flexible, cost-effective commercial pharmaceutical manufacturing services
NPIL Pharma is one of the very few CMO's in the world forward integrated from API/Intermediates development and manufacturing into final dosage forms.
Company:
Norac Pharma
Booth:
1676
Media Contact:
Kirsten Johnson
Phone:
626-812-5538
E-mail:
kjohnson@norac.com
Web:
www.noracpharma.com
Norac Pharma is a Contract service company who handles outsourcing of API Manufacture, Process Development, and Analytical services. Centrally located in California, we are the ideal partner for local companies seeking to outsource API production.
With almost five decades of experience in manufacturing APIs, and expertise in the production of Controlled Substances and Potent Compounds, Norac Pharma delivers a timely, efficient, and compliant product.
Company:
North Carolina Biotechnology Center
Booth:
1655
Media Contact:
Jim Shamp, News and Publications Editor
Phone:
919-541-9366
E-mail:
Jim_shamp@ncbiotech.org
Web:
www.ncbiotech.org
The North Carolina Biotechnology Center is a private, non-profit corporation established in 1984 as the world's first government-sponsored biotechnology initiative. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide.
Headquartered in Research Triangle Park, the Center has five small offices across the state to encourage regional and niche development of biotechnology. The Center is supported by the state's General Assembly and has a budget is $17.6 million and a staff of 65.
North Carolina has the nation's third largest biotechnology industry with 350 bioscience companies employing 48,000 people. Visit www.ncbiotech.org.
Company:
North Carolina Department of Commerce
Booth:
Pavilion 1655
Media Contact:
Mira Meghdessian
Phone:
646-351-3510
E-mail:
mira.meghdessian@dc-intl.com
Web:
www.nccommerce.com
North Carolina: The State of Minds. North Carolina's knowledge-based workforce, combined with a network of support organizations focused on collaboration, offers many strategic advantages for the biotechnology, pharmaceutical, and life science industries. Over 350 bioscience companies employ 48,000 people in the state. And North Carolina provides innovative programs to train and replenish this talent pool.
The North Carolina Community College System, the largest per capita in the nation, provides specialized training through its BioNetwork initiative. The North Carolina Biotechnology Center is the world's first government-sponsored organization dedicated to developing the biotechnology industry.
Learn more at the North Carolina Pavilion (#1655).
Company:
NOTOX B.V.
Booth:
2633
Media Contact:
marketing@notox.nl
Phone:
31736406700
E-mail:
marketing@notox.nl
Web:
www.notox.nl
NOTOX B.V. is a leading contract research organization, providing full safety, toxicology and consultancy services for the pharmaceutical industry, non-clinical testing, in vitro / in vivo toxicology, kinetics and metabolism studies.
Toxicology research is supported by an extensive (bio-)analytical laboratory facility, method validation and metabolite identification. NOTOX has over 70 scientific and regulatory advisors with many years of experience in the non-clinical development of NCE's and biologicals. Our consultants, scientists and project coordinators, use their knowledge and experience to design complete programs for each specific compound from lead to Phase I clinical trial. NOTOX B.V. is part of a world wide group of autonomous companies providing toxicology research services for the pharmaceutical industry. NOTOX, Dedicated Crystal Clear
Company:
Nucleus Network
Booth:
#1515
Media Contact:
Maria Chiam
Phone:
415 606 5839
E-mail:
m.chiam@clinicaltrialsconsulting.com.au
Web:
www.nucleusnetwork.com.au
Quality driven clinical trials conducted on-time and on-budget in Australia for biotech, pharma and medical device companies. Services include:
•Specialised Phase I and early phase capabilities;
•24 bed state-of-the-art in-patient facilities for early phase studies with access to diverse patient and volunteer populations;
•Continuous cardiac monitoring (telemetry);
•Clinical trial consulting services to create a full clinical development plan and regulatory filings for clinical trial approval and marketing authorisation for Australian and international agencies such as TGA, FDA and EMEA;
•Commercial sponsorship for international companies without a corporate presence in Australia available.
Company:
NYC Economic Development Corporation -- Bioscience Desk
Booth:
1833
Media Contact:
Bill Fair, Managing Director
Phone:
212 312 3836
E-mail:
bfair@nycedc.com
Web:
www.nycbiotech.com
Mayor Bloomberg has made bioscience a key priority and projects being addressed by NYC's Bioscience Desk include the East River Science Park. New York City unique bioscience assets include:
--Talent -- NY metro area has the largest bioscience workforce
--Research -- $1.3B in NIH awards and the largest concentration of academic institutions
--Funding -- Wall Street access and 125 healthcare venture capital firms
--Lab/Office Space -- office, sales and research labs are here. ERSP will feature 1.1 M sf of offices/labs
--More international flights than any US City
--115 bioscience firms recognize the advantage of their NYC location
Company:
NYCOMED
Booth:
hospitality suite at Westin Waterfront Hotel (adjacent to Convention-centre)
Media Contact:
Morten Faester
Phone:
45 4056 6888
E-mail:
MOR@nycomed.com
Web:
www.nycomed.com
NYCOMED is the European specialty pharma which recently acquired Altana-Pharma.
NYCOMED is active in licensing-in of mid-stage projects for co-development and European commercialization -- as well as out-licensing a couple of late-stage projects for US-partnering.
The therapeutic focus areas includes: Pain-management, Hospital cardiology, Respiratory, GI, Osteoporosis and Surgery-management.
Amongst the out-licensing opportunities available are the "Instanyl" nasal fentanyl for breakthrough pain.
Company:
Ocimum Biosolutions
Booth:
Booth No.# 2500
Media Contact:
Ashwin Sivakumar
Phone:
00 91 40 66627200-04
E-mail:
ashwin.s@ocimumbio.com
Web:
http://www.ocimumbio.com
Ocimum Biosolutions is a leading integrated life-sciences R&D enabling company providing focused solutions for enabling different steps of the life-sciences process chain. Our strategic presence in USA, Netherlands and India helps us offer cutting edge technologies at competitive market rates.
Our BioMolecules division provides complementary product lines in Microarrays and Oligos using sophisticated proprietary technologies while adhering to strict quality standards. Through our Ocichip™ technology, we offer one of the widest ranges of catalog arrays and flexible custom arrays with superior probe design. We offer QUTE (Quantitativel Unique Technique Extracted) oligos with stringent quality controls using proprietary purification technology which is in par with HPLC.
Our Bioresearch division with sophisticated world-class facilities offers a variety of analytical research services in the Molecular Biology space ranging from Sequencing services to gene synthesis.
Our BioIT division provides flexible end to end solutions for management and analysis of complex biological data.
Company:
OmniLingua Inc
Booth:
2372
Media Contact:
Tracie Williams
Phone:
319-892-8119
E-mail:
twilliams@omnilingua.com
Web:
www.omnilingua.com
OmniLingua Inc, as your globalization management partner, will assist you in developing your global presence, reducing your time to market, and minimizing your risk in new markets. Our precise balance of highly skilled industry-specific experts, global technology systems professionals and the power of the OTIS™ Management System -- proven personnel, processes and tools -- can be implemented successfully in any cultural environment. We ensure that your globalization management needs are fulfilled accurately and at the lowest cost over the long-term. At OmniLingua our focus is crystal clear -- delivering focused globalization management quality, service and technology to achieve your global service needs.
Company:
Oncolytics Biotech Inc.
Ticker Symbol & Exchange:
NASDAQ:ONCY, TSX:ONC
Media Contact:
Cathy Ward
Phone:
403.670.7370
E-mail:
cathy.ward@oncolytics.ca
Web:
www.oncolyticsbiotech.com
Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers.
Oncolytics has completed six clinical trials with REOLYSIN® in Canada, the U.K. and the U.S. and is currently conducting or has approval to commence seven Phase I or Phase II REOLYSIN® trials in the U.K. and the U.S.
The current clinical program includes local or systemic delivery of REOLYSIN® as a monotherapy, and local or systemic delivery of REOLYSIN® in combination with radiation or chemotherapy for patients with advanced cancers.
Company:
Onondaga County - Syracuse NY
Booth:
1833
Media Contact:
Greg Hitchin
Phone:
315-435-3770 or 315-427-8583 (at show)
E-mail:
ghitchin@ongov.net
Web:
www.SyracuseCentral.com
Syracuse and Central New York is a great place to do business! Known as a center of innovation since the 19th century, the community maintains the spirit of innovation while transforming itself into a success in the new economy. Two new initiatives, the CNY Biotechnology Research Center and the Center of Excellence for Renewable Energy will help fuel the regions continued success. A highlight of the area is the new 250-acre Life Science business park. Located in a suburban section of Onondaga County, the Park features the seclusion of a rural setting with easy access to housing, shopping, and airport.
Company:
Open Biosystems, Inc.
Booth:
Alabama Pavilion/ 1742
Phone:
256-704-4848
E-mail:
info@openbiosystems.com
Web:
www.openbiosystems.com
Open Biosystems offers products that span Genomics, RNAi and Antibodies. Building on the rapid sharing model that is at the core of the Human Genome Project, Open Biosystems collaborates with some of the most innovative life science investigators working today. We partner with them to bring to market new products--they have often pioneered the new resources in their own lab, and we prepare it for widespread use and then provide access to the research community.
We offer the most complete library or genes in the industry. This novel library consists of several full length cDNA and open reading frame collections.
Company:
Optimata
Booth:
Israeli Pavilion (3171)
Media Contact:
Guy Malchi, CEO
Phone:
972-3-7519226
E-mail:
info@optimata.com
Web:
www.optimata.com
Optimata is a modeling based biopharma company that develops computerized tools, Virtual Patient engines, for navigating drug development towards better drugs, faster.
Applying biomathematics to develop a predictive bio-simulation software toolkit, this technology provides a comprehensive drug development solution.
It thoroughly unfolds drug patient dynamic interactions, enabling drug developers to perform rapid virtual clinical trials and to forecast optimal drug regimen patient population clinical indication match for a given trial end point.
Optimata's Technology Enables
•Drug repurposing
•Enhanced drug competitive profile
•Early "GO/NO-GO" development decisions
•Drug safety profile
•Optimal dosing schedules
•Clinical indication selection/expansion
Company:
OpStat Group Inc.
Booth:
1371 in Connecticut Pavilion
Media Contact:
Jim Curry
Phone:
203.431.3905
E-mail:
JimCurry@OpStat.com
Web:
www.OpStat.com
With 20-years biopharma experience, OpStat has developed models for capacity, performance and cycle time improvement in manufacturing and laboratory operations. OpStat's simulations and methodology analyze alternatives for equipment, inventory and staffing for R&D, clinical trials, tech transfer and commercial production.
Covering the full scope of the supply chain from cell fermentation, formulation, filling, to packaging, the models include all forms of products -- including liquids, solids, lyophilized vials and syringes, transdermals and specialized delivery. Detailed processing, decontamination and cleanout rules provide real-world predicted results.
Laboratory models with attribute test profiles may be used for stand-alone planning or integrated into manufacturing flows.
Company:
Orion Corporation
Booth:
2065 Scandinavia Pavilion
Ticker Symbol & Exchange:
ORNAV, ORNBV (OMX, Helsinki)
Media Contact:
Tuula Laitinen, Communications Manager
Phone:
358 50 966 2136
E-mail:
tuula.laitinen@orion.fi
Web:
www.orion.fi
Orion Corporation Orion Pharma is competent in R&D to take products from discovery to MA. Therapy areas CNS, CV and HTU. We provide supportive partnership with the early stage projects. We look for strategic partnerships with universities and companies. Our business includes research, manufacturing and marketing, Northern Europe as home territory.
Company:
Otsuka Pharmaceuticals - ODPI Division
Booth:
1884
Media Contact:
Mr. Koji Yoneda, Director, BD
Phone:
81-6-6231-7158
E-mail:
odpiweb@otsuka.jp
Web:
http://otsuka-odpi.com
Otsuka Pharmaceutical Co., Ltd. has developed a new DPI System (ODPI System) utilizing a unique lyophilizing technique, by which the company has efficiently formulated proteins, peptides, and chemicals and achieved the easy inhalation of these drugs. The ODPI System comprises a freeze-dried formulation with novel excipients, and a unique yet simple manufacturing method, and a compact and easy--to-use inhalation device. Differing from conventional inhalation systems that require prior pulverization of the drug, the ODPI System achieves micronization of the drug substance with the air impact of a single intake of breath, enabling simultaneous micronization and inhalation.
Company:
PAA Laboratories Inc.
Booth:
1181
Media Contact:
Mark Ferreira
Phone:
508-984-5881
E-mail:
USinfo@paa.com
Web:
www.paa.com
PAA specializes in the manufacture and worldwide distribution of cell culture products for research, development, diagnostic and biopharmaceutical production. The company processes and manufactures animal & human sera, synthetic media, protein-free media, biochemical supplements and reagents, all of which are used as cell nutrients in cell culture technology. PAA is a privately held company with sales in excess of 32M Euros, with manufacturing operations in Europe, North America and Australia, and sell products in over 40 countries world-wide through direct sales and distributors.
Company:
PaleoTechnology International
Booth:
1620
Media Contact:
Bevo Beaven, CTA Integrated Communications
Phone:
(303) 665-4200
E-mail:
bevo@ctaintegrated.com
Web:
www.ctaintegrated.com
PaleoTechnology International is a technology development and commercialization company creating bio-based products and processes that increase the value derived from natural resource environments. This happens through innovative Bio/Chemical Discovery and Bioprocess Development in diverse environments including petroleum extraction sites, extreme environments, and in zones of significant biodiversity. These specialty products and processes represent the highest and best use of resources from these environments, and contribute to solving global problems associated with existing technologies.
PaleoTechnology, in partnership with the Box Hill Institute in Melbourne, Australia will collaborate on the development of novel products and bioprocesses derived from diverse natural resource environments.
Company:
Palm Beach Gardens, Florida
Booth:
1073
Media Contact:
Dolores Key
Phone:
561.799.4136
E-mail:
bio@pbgfl.com
Web:
www.pbgfl.com
With cosmopolitan flair and hometown feel, Palm Beach Gardens is your passport to a superb quality-of-life: average sunny temperature of 78°F; proximity to two international airports; beautiful parks and preserves; pristine area beaches; fine shopping and dining; and home of Scripps Florida.
Located on Florida's east coast, Palm Beach Gardens is the epicenter of a burgeoning business community and is home to many notable corporate headquarters: the newest campus of Bascom Palmer Eye Institute, Anspach Companies, 3i, and TransDermal Technologies, compliment the scientific environment.
The Gardens - your ticket to an environment that nurtures success.
Company:
PAREXEL International Corporation
Booth:
533
Ticker Symbol & Exchange:
NASDAQ Exchange: PRXL
Media Contact:
Rebecca Passo, SHIFT Communications
Phone:
617-779-1817
E-mail:
rpasso@shiftcomm.com
Web:
www.PAREXEL.com
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. PAREXEL will be sponsoring and exhibiting its range of developmental and commercialization services at the 2007 BIO International Convention in the MBC Massachusetts Pavilion, the largest state pavilion. PAREXEL is a Massachusetts Biotech Council (MBC) member and Massachusetts-based, international company. Visit PAREXEL's Booth #533 to learn about the Company's continuing focus on small/emerging biopharmaceutical companies and view a demonstration of its advanced technologies by PAREXEL's subsidiary, Perceptive Informatics.
Company:
Partnership for Biotechnology Research (PBR)
Booth:
AL pavilion
Media Contact:
Amanda Wallace
Phone:
256-319-1420
E-mail:
info@alpbr.org
Web:
www.alpbr.org
The Partnership for Biotechnology Research (PBR), a not-for-profit organization, catalyzes and supports the biotechnology entrepreneurial and educational efforts in Huntsville, Alabama. Through quarterly events, PBR highlights national speakers and local research efforts. Activities focus on developing the current and future biotechnology workforce. Established in 2003, PBR now consists of over 250 people from Greater Huntsville. Members range from biotechnology entrepreneurs and employees, to university students and faculty, to a wide range of service and support providers. Visit www.alpbr.org, PBR's online community, for local press releases, details and photos of PBR's events and activities and local job and resume postings.
Company:
PCI Synthesis
Booth:
533 / A26
Phone:
978-463-4810
E-mail:
sales@pcisynthesis.com
Web:
www.pcisynthesis.com
PCI Synthesis is a specialty chemical company that manufactures API's and custom chemicals for pharmaceutical, biotech and medical device companies. PCI offers a full complement of process research, development and manufacturing services from single grams to metric tons.
PCI has the proven ability to navigate the regulatory processes with its cGMP manufacturing status and DMF submissions. The company is harmonized to the ICH guidelines and is Part 11 7a compliant. PCI has undergone both general site and pre-approval inspections from the FDA at its manufacturing plant in Newburyport, MA and its research center in Devens, MA facilities.
Company:
Pennsylvania Bio
Booth:
Pennsylvania Pavilion -- Booth 1440
Media Contact:
Karla White
Phone:
610-578-9220
E-mail:
karla@pennsylvaniabio.org
Web:
www.pennsylvaniabio.org
Pennsylvania Bio is the Voice of Advancement for the biosciences community in Pennsylvania, representing the continuum of the industry--research institutions; emerging biotech, device, and diagnostic companies; global pharmaceuticals; and support organizations. Pennsylvania Bio serves as a point of contact for information on the bioscience industry in Pennsylvania, including industry trends, the industry's impact on the commonwealth's economy, workforce initiatives, and public policy and its impact on the biosciences.
Company:
Pennsylvania Department of Community and Economic Development
Booth:
Pennsylvania Pavilion, Booth 1440
Media Contact:
Ted Martin
Phone:
717-720-1388
E-mail:
themartin@state.pa.us
Web:
www.newpa.com
Pennsylvania is the center of life science innovation --world-class basic research, emerging companies, mature industry, global pharmaceuticals and support organizations. Our $2 billion Life Sciences Enterprise commitment and $2.8 billion Economic Stimulus program are unrivaled. Make your business investment succeed. Put Pennsylvania in your future.
Pennsylvania Department of Community and Economic Development
Commonwealth Keystone Building
400 North Street, 4th Floor
Harrisburg, PA 17120
800-237-4363
www.newPA.com
Company:
Pennsylvania State University, The
Booth:
1440 - Pennsylvania Pavilion
Media Contact:
Bill Mahon
Phone:
814-863-1028
E-mail:
bmahon@psu.edu
Web:
http://www.psu.edu
Penn State offers research partnering, training, and educational opportunities in medical devices; drug delivery and discovery; biomaterials; nanobiotechnology; bioinformatics; pharmaceutical and health industry management; and bio-based materials and products for agricultural applications. The Penn State Industrial Research Office (www.iro.psu.edu) is available to assists companies in accessing these opportunities through the Hershey Medical Center, The Huck Institutes of the Life Sciences, Materials Research Institute, and College of Agricultural Sciences.
Company:
PerkinElmer Life and Analytical Sciences
Booth:
2202
Ticker Symbol & Exchange:
NYSE symbol: PKI
Media Contact:
Sigrid Tehrani
Phone:
508-241-2697
E-mail:
Sigrid.tehrani@perkinelmer.com
Web:
Perkinelmer.com
PerkinElmer's OneSource is a business improvement solution that provides the skills and capabilities necessary to enable Scientists to focus on Science. Our one-contact, one-contract solutions lower costs, increase productivity and enhance regulatory compliance. OneSource offers scalable, tailored business solutions for all lab equipment maintenance and asset management activities. Through consolidated and proactive management, OneSource provides customers with better control of their maintenance costs and improves laboratory productivity through increased uptime. For additional information about OneSource, contact PerkinElmer at (781) 663-6900.
Company:
Perkins Coie LLP
Booth:
1266
Media Contact:
Julie Kaplan
Phone:
310.788.3287
E-mail:
JLKaplan@perkinscoie.com
Web:
www.perkinscoie.com
Perkins Coie serves great companies ranging in size from FORTUNE 100 companies to start-ups. The firm has more than 600 attorneys in 15 offices across the United States and in China and has historically represented market leaders in traditional and cutting-edge technology industries. We employ a multidisciplinary approach to provide a comprehensive range of legal services to life sciences clients at every stage of growth.
Company:
PIERRE FABRE MEDICAMENT Active Ingredients Division
Booth:
1424
Media Contact:
Yann BAYEUX
Phone:
33.563.81.24.00
E-mail:
Yann.bayeux@pierre-fabre.com
Web:
www.plantes-industrie
PFM - active ingredients division, is focused on new process development, industrialization and commercial production of cGMP APIs. We are active in cytotoxic APIs : vinorelbine, vinflunine, etoposide etc... We are also highly skilled in natural product extraction and purification. We are equipped with continuous extraction chains to extract up to 1t/h of dried plant. The material can then be purified by HPLC (450mm) and some chemical steps can be added. Based on our know-how in SuperCritical Fluids, we have developed a multi-purpose technology platform : Nanoparticles, FORMULPLEX® and FORMULCOAT® used in bioavailability/solubility enhancement, taste masking or micronization.
Company:
Pittsburgh Regional Alliance
Booth:
1440 -- Pennsylvania Pavilion
Media Contact:
Bernie McShea
Phone:
412-260-6464
E-mail:
bmcshea@pittsburghregion.org
Web:
www.pittsburghregion.org
The Pittsburgh Regional Alliance is the regional economic development and investment promotion agency for the Pittsburgh, Pennsylvania area. We maintain close relationships with leading life sciences companies in our region such as Medrad, Bayer, Respironics, and Cellomics, and have assisted in locating and expanding them in our region. We are quite knowledgeable about life sciences investment trends in our region, both among private companies as well as world-class research institutions (e.g., University of Pittsburgh, Carnegie-Mellon University).
Company:
PharmaCell
Booth:
Netherlands Pavilion #2633
Media Contact:
Maurice M.M. Horsten, VP Marketing & Sales
Phone:
31-43-3509910
E-mail:
m.horsten@pharmacell.nl
Web:
www.pharmacell.nl
PharmaCell is a Life Science company providing know-how and resources for product an process design combined with GMP manufacturing in its own facility. PharmaCell is located in the Biopartner Center Maastricht and, therefore, can take advantage of an extensive network to mediate in R&D, financing and housing requirements of the clients. Close cooperation with the Maastricht University and the associated Academic Hospital gives PharmaCell the unique capability to provide support and/or partnership to R&D companies to bring new products from the lab into the clinic.
Company:
PLANET LLC
Booth:
1133
Media Contact:
Ms. Marty Gustafson
Phone:
608-827-5555
E-mail:
gustafsonm@hypercosm.com
Web:
www.planet-lcc.com
PLANET LLC strives to transition technologies from initial development stages to viable commercial markets. Under a strategic alliance with Orbital Technologies Corporation, PLANET LLC has advanced space-based technologies into products for the life sciences, education, space resources, and biomedical markets. Offerings include LED lighting, plant-growth systems, lunar simulant, web-based 3D software and physical rehabilitation.
PLANET LLC is currently focused on the commercialization of controlled environment capabilities into controlled agricultural manufacturing for new products such as medicines, nutraceuticals, and other protein chemistry that utilize plants as key step in production.
Company:
Praxair, Inc.
Booth:
1007
Ticker Symbol & Exchange:
PX (NYSE)
Media Contact:
Hope Dipierro
Phone:
203-837-2573
E-mail:
Hope_dipierro@praxair.com
Web:
www.praxair.com/biopharma
Praxair supports key stages in the lifecycle of biopharma product development, assuring consistent quality, efficiency and reproducibility from discovery to scale-up to production.
Praxair, Inc. is the largest industrial gases company in North and South America, and one of the largest worldwide, with 2006 sales of $8.3 billion. The company produces, sells and distributes atmospheric and process gases, and high-performance surface coatings. Praxair products, services and technologies bring productivity and environmental benefits to a wide variety of industries, including aerospace, chemicals, food and beverage, electronics, energy, healthcare, manufacturing, metals and others. More information on Praxair is available at www.praxair.com
Company:
Primorigen Biosciences LLC
Booth:
1139
Media Contact:
Chuck Oehler
Phone:
608-441-8334
E-mail:
info@primorigen.com
Web:
www.primorigen.com
Primorigen Biosciences LLC is a leader in developing fluorescent, multiplexed immunoassays for detecting protein biomarkers for cell therapy research and other applications. The company offers complete contract capabilities for rapid monoclonal antibody development, custom assays and microarrays, cDNA cloning, protein expression/purification, and automated statistical design of experiment optimization. Partnering interests include match pair antibodies, novel substrates and slides for microarrays, systems for protein quantification and total cell characterization, novel detection systems, and related technologies. Primorigen's scientists come from leadership roles at some of the world's prominent biotechnology companies. The company recently expanded operations at University Research Park in Madison, WI.
Company:
ProNAi Therapeutics, Inc.
Media Contact:
Mario Fante, Aviator PR
Phone:
617-763-9887
E-mail:
mario@aviator-pr.com
Web:
www.pronai.com
ProNAi Therapeutics, Inc. is a biopharmaceutical drug development company pioneering a new class of nucleic-acid drugs based on DNA interference (DNAi®), which employs single strands of DNA to target and treat non-transcribed regions of genomes responsible for complex genetic diseases. ProNAi is developing multiple DNAi® drug candidates with the potential to treat multiple cancers, including non-Hodgkin's lymphoma, prostate, breast, and colon cancers. The company's lead drug candidate, PNT2258, which has demonstrated in vivo efficacy in a variety of human tumor xenograft models, is currently in preclinical development. ProNAi is also exploring the potential of DNAi® therapies for indications beyond oncology.
Company:
Pronota nv
Booth:
Stand 3033, Belgium Pavilion
Media Contact:
Sofia Vindevogel
Phone:
32 9 241 11 64
E-mail:
Sofia.vindevogel@pronota.com
Web:
www.pronota.com
Pronota, the Belgium-based protein biomarker company, is developing a new generation of diagnostic and pharmacodiagnostic products based on protein biomarkers. The Company's advanced technology identifies protein biomarkers in biological samples that provide insight in disease etiology. It can also identify protein biomarkers that distinguish between patients that will and will not respond to certain drugs to determine best treatment options. Pronota also provides contract research services for protein biomarker discovery to pharmaceutical and diagnostic companies.
To find out more about Pronota and its exciting developments in the protein biomarker field, come and talk to Koen Kas, Chief Scientific Officer, at stand 3033.
Company:
ProTecs
Booth:
Pennsylvania Pavilion Booth #1440
Media Contact:
Christopher R. DiPaolo
Phone:
610-941-1001 ext.380
E-mail:
cdipaolo@protecsinc.com
Web:
www.protecsinc.com
ProTecs is a technically based professional services company providing program/project management, construction management, commissioning and integrated design/build services to emerging, small and mid-size biotechnology, pharmaceutical, medical device, healthcare, higher education and technology based companies. ProTecs was founded in 2005 to provide creative, value-driven approaches and entrepreneurial solutions to help companies bring their products to market in the most cost effective and timely manner. ProTecs aligns themselves with their clients' stated long-term strategic business objectives to meet their process, compliance, financial and time to market goals.
Company:
Protein'eXpert
Booth:
2057 -- France Pavillion
Media Contact:
Christelle Dagoneau, Business Development Director
Phone:
33 438 023 650
E-mail:
marketing@proteinexpert.com
Web:
www.proteinexpert.com
Funded in 2000 in Grenoble, France, Protein'eXpert is an expanding CMO devoted to recombinant protein engineering & production for biomedical research applications. Our 36-staff company offers custom-designed services focusing on the discovery, optimisation and production of valuable target or therapeutic proteins. Since 2004, Protein'eXpert has extended its offering to the cGMP biomanufacturing of therapeutic protein products for early clinical trials via its integrated subsidiary PX'Pharma. The combination of Protein'eXpert and PX'Pharma know-how and manufacturing capacities allows ensuring a seamless transfer from therapeutic protein development up to clinical production stages.
Company:
Proteologics
Media Contact:
Mrs. Anna Khazanov
Phone:
972-8-9475666
E-mail:
anna@proteologics.com
Web:
www.proteologics.com
Proteologics to present at the 2007 Business Forum.
Proteologics is a leading force in translating the ubiquitin system into novel therapeutics. Drs. Avram Hershko and Aaron Ciechanover - the Nobel Prize laureates for the discovery of the ubiquitin system- chair the company's scientific advisory board.
Proteologics' Rational Target & Drug Discovery Platform has already yielded several drug discovery programs, in antivirals, cancer and CNS.
Proteologics is looking for strategic partners that like to benefit from Proteologics' unique expertise in target discovery, assay development & drug discovery in the ubiquitin system as well as in lead development and siRNA technology.
Company:
Quincy Bioscience, LLC
Booth:
Wisconsin Pavilion
Media Contact:
Dakota Miller
Phone:
608-233-2475
E-mail:
dmiller@quincybioscience.com
Web:
www.quincybioscience.com
Quincy Bioscience is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat the diseases of aging. The company's therapeutic products focus on alleviating the consequences of impaired calcium homeostasis - the imbalance of calcium ions commonly thought to be related to neurodegenerative diseases such as Alzheimer's and Parkinson's. Quincy Bioscience is set apart by its cutting-edge applications of the calcium-binding protein aequorin, breaking new ground in the fight against age-related disease. Quincy Bioscience has also successfully developed the dietary supplement Prevagen™ (www.prevagen.com) and is launching this product on September 1, 2007.
Company:
Qserve
Booth:
Hall C, stand 2633
Media Contact:
W.W.M. Driessen
Phone:
31 20 410 1250
E-mail:
info@qservegroup.com
Web:
www.qservegroup.com
Qserve® is an independent medical device regulatory consulting firm with offices in the Netherlands and USA. Qserve has considerable in-house expertise in the areas of life science, medical device, biotechnology and regulatory compliance consulting, which include strategic approach, due diligence & GAP analysis, product compliance, pre-clinical, training, auditing and quality management systems implementation.
Company:
Q Therapeutics, Inc.
Booth:
Utah Pavilion #2707
Media Contact:
Deborah Eppstein
Phone:
801-556-5004
E-mail:
deppstein@qthera.com
Web:
www.qthera.com
Q Therapeutics has taken an innovative and practical approach to developing products to treat currently untreatable, debilitating diseases of the central nervous system. Q-Cells™ is a cell-based therapeutic that does naturally what no other drug can - it replaces the insulating myelin on damaged neurons and thus regenerates normal function of these neurons. Q-Cells are applicable to a wide range of demyelinating diseases, including MS, cerebral palsy, spinal cord injury and white matter stroke.
Company:
Quebec Government
Booth:
1020
Phone:
514 499-2199, ext. 3310
E-mail:
nancy.carignan@mdeie.gouv.qc.ca
Web:
Mdeie.gouv.qc.ca/bio2007
Discover the advantages of investing and doing business in Quebec, a world-leader in life sciences and stand a chance to win a free weekend at the Montreal International Jazz Festival. At Quebec Pavilion, booth 1020, meet specialists who will explain why your expansion projects should be carried out in Quebec. In private meeting rooms you will learn about fiscal incentives, financing, wage-competitive talent, etc. In Quebec we grow creativity and build on talent. www.mdeie.gouv.qc.ca/bio2007
Company:
Queensland Government
Booth:
Australia Pavilion (1515)
Media Contact:
Elouise Campion
Phone:
61 7 3224 6784
E-mail:
elouise.campion@ministerial.qld.gov.au
Web:
www.biotech.qld.gov.au
Beautiful weather, pristine beaches, relaxed lifestyle...combine these with our internationally renowned scientists, world class infrastructure, rich biodiversity and you have the perfect climate for biotechnology businesses.
Company:
R5 Pharmaceuticals
Booth:
1679
Media Contact:
PAUL TITLEY
Phone:
44 115 912 4410
E-mail:
p.titley@r5pharma.com
Web:
www.r5pharma.com
R5 Pharmaceuticals is a contract service provider in drug development for the pharma and biotech industries. Based on the BioCity campus, Nottingham, R5 uses an efficient and integrated approach to pharmaceutical development, from drug formulation and delivery technology through to full scale manufacture. Led by a uniquely experienced management team, R5 Pharmaceuticals provides solutions for the development of safe and effective pharmaceutical materials to be used in clinical studies. The facilities include one of the very few cleanrooms in Europe, enabling the highest level of sterile product development. R5 is also applying its expertise to rapidly evolving areas such as paediatric products and nutraceuticals.
Company:
Randox Laboratories
Booth:
1881
Media Contact:
Glenn Morton
Phone:
44 (0) 28 9442 2413
E-mail:
marketing@randox.com
Web:
www.randox.com
Randox Laboratories Ltd is a privately owned diagnostic reagent and equipment manufacturer and the leading British manufacturer of clinical chemistry reagents. Randox has 25 years experience in research, development, manufacture and marketing of high quality diagnostic reagents and equipment for laboratory medicine. The Randox portfolio includes Biochip Array Technology, clinical chemistry automation systems, external quality assurance schemes, internet driven QA systems, quality control materials, clinical reagents and environmental diagnostics.
Company:
Raven biotechnologies, inc.
Media Contact:
Joseph Fisher
Phone:
650-624-2656
E-mail:
jmfisher@ravenbio.com
Web:
www.ravenbio.com
Raven biotechnologies, inc. is focused on the discovery of new drug targets for life-threatening conditions and the development of antibody products to treat them. Raven develops monoclonal antibody therapeutics, discovery tools, and technologies using unique, tissue-specific stem (i.e. progenitor) and tumor cells as antigens. Raven is currently focused on developing MAb therapies for cancer. The company's first clinical drug, RAV12, is a therapeutic antibody against a novel target present on GI cancers (pancreatic, stomach, and colon) as well as other adenocarcinomas. RAV12 is currently in a US multicenter Phase I Clinical Trial and will begin Phase II trials in mid-2007.
Company:
Regeron, Inc.
Booth:
2436 - Korea Pavilion
Media Contact:
Dahlkyun Oh, Ph.D.
Phone:
82-33-258-6262
E-mail:
dahlkyun@regeron.com
Web:
www.regeron.com
Regeron, Inc. - Strives for the healthy and productive long-life through innovative medicine that improves and even reverses natural and pathological manifestations of the old; Develops anti-aging biotech products-especially proteins for cosmetic and pharmaceutical industries. Currently on the market are hGH (human growth hormone) products for cosmetic purposes. Its long term goal is to develop an oral/pulmonary delivery system for protein drugs.
Company:
Renewable Energy Group, Inc.
Booth:
Iowa Pavilion Booth 1356
Media Contact:
Alicia Clancy
Phone:
712-667-3418
E-mail:
Alicia.clancy@regfuel.com
Web:
www.regfuel.com
Renewable Energy Group®, Inc. is the biodiesel industry leader of B100 sales and is the only full-service biodiesel company offering plant management, risk management, raw material procurement, plant construction, biodiesel production and biodiesel sales and marketing services. By 2008, REG's network of commercial scale biodiesel plants will have more than 200 million gallons of biodiesel available to the growing marketplace.
Company:
Rentschler Biotechnologie GmbH
Booth:
1055/1057
Media Contact:
Friederike Braun
Phone:
0049 7392 701 555
E-mail:
biotech@rentschler.de
Web:
www.rentschler.de
Rentschler Biotechnologie is an independent, internationally operating service company that has been established in the field of biopharmaceuticals for over 30 years.
With an all-inclusive package of integrated services, we can support you in all phases of product development. Our experienced staff develops your product through an integrated, custom tailored offer of biopharmaceutical services from the cell line to registration.
GxP certified services:
•Cell Line & Process Development
•Production of Active Pharmaceutical Ingredients
•Fill and Finish
•Analytics & Quality Control
•Regulatory Affairs & Quality Assurance
•Corporate Project Management
Company:
Restaino Bunbury & Associates Realtors
Booth:
Wisconsin Pavilion
Media Contact:
Bette McCarthy, CRP/GMS
Phone:
608-833-7777
E-mail:
mccarthy@restainobunbury.com
Web:
www.madisonrelocation.com
Full Service Relocation, Real Estate Firm. Delivering world class services such as Home-finding, Rental Assistance. Community Tours, Trailing Partner Program and much more!. Specializing in local and global relocations. A silver member and the preferred vendor for the Wisconsin Biotech and Medical Device Association.
Company:
Rondaxe Pharma L.L.C.
Booth:
New York Pavilion, Booth 1833
Media Contact:
Ann Kich
Phone:
315 469-2800 ext 202
E-mail:
akich@rondaxe.com
Web:
www.rondaxe.com
Rondaxe Pharma is a consulting firm that employs a diverse group of senior level staff from the pharmaceutical industry with expertise in chemical development, fermentation development, drug product development, supply chain strategy, analytical development, manufacturing operations, quality control, quality assurance, and regulatory affairs. Using our systematic approach, combined with depth and breadth of experience, Rondaxe's proactive strategies position our customers for success. Rondaxe's staff supports our clients with advice & council or will perform the work, providing full implementation and execution capabilities. By working with Rondaxe, our clients benefit by gaining one point of contact to the broader multi-disciplined team.
Company:
SAGI
Booth:
1408
Media Contact:
Jacques-Henry VERGNE & Emmanuelle JOUANNET
Phone:
33 1 40 75 33 04
E-mail:
delehonte@sagi-immo.com
Web:
www.sagi-immo.com
Company:
San Francisco East Bay EDA
Booth:
1569
Media Contact:
Keith Sutton
Phone:
510 272-3885
Source: Business Wire
Related Articles
- Think Services Game Group's Game Developer Research Finds Outsourcing in the Game Industry Increasing in 2009 Game Development Outsourcing Report
- Premier Research Announces Milestone Investigational New Drug Application
- Media Monitoring, Research & Information Services From EIN News Overhauled; News Customization, Access to Editorial Staff Available
- Research and Markets: Crosstex Energy Services Company Profile Provides All The Crucial Company Information Required For Business And Competitor Intelligence Needs
- GTC Biotherapeutics Enters into Process Development and Clinical Supply Manufacturing Services Agreement With PharmAthene for Protexia(R)
- IR BioSciences Holdings, Inc. To Collaborate With Leading Clinical Services Company to Evaluate Radilex(TM) in Low-Level Radiation Exposure
- Auroras and Broadstream Will Combine to Create Avail Media, a Leading Next Generation Media Services Company
- NovaShunt AG, a Medical Device Company Focused on Implantable Fluid Management Systems, Appoints Fiona Sander, MSME, As Director of Research & Clinical Affairs
- Cirrus Health Appoints Barry D. Smith As Vice President of Clinical Service Line Development
- PMSI-Tmesys Appoints Vice President of Clinical Services and Business Development
 |
 |
User Comments (0)
RSS Feeds